Retrospective analysis of 23 Chinese children with congenital hyperinsulinism undergoing pancreatectomy

Lin Zhang1, Zi-Di Xu1, Min Liu1

  • 1Department of Endocrinology, Genetics and Metabolism Centre, Beijing Children's Hospital, Capital Medical University, National Centre for Children's Health, Beijing, China.

Endokrynologia Polska
|July 22, 2021
PubMed

Insights

Pancreatectomy effectively treats congenital hyperinsulinism (CHI). ¹⁸F-DOPA PET/CT scanning accurately diagnoses CHI types, with partial pancreatectomy offering a high cure rate for focal CHI.

Area of Science:

  • Pediatric Surgery
  • Endocrinology
  • Medical Imaging

Background:

  • Congenital hyperinsulinism (CHI) is a rare disorder of insulin excess.
  • Pancreatectomy is a potential treatment for severe CHI.
  • Accurate diagnosis and localization are crucial for effective surgical management.

Purpose of the Study:

  • To evaluate the therapeutic effect and prognosis of pancreatectomy in Chinese children with CHI.
  • To assess the role of ¹⁸F-DOPA PET/CT in diagnosing CHI subtypes and guiding surgical decisions.

Main Methods:

  • Retrospective analysis of 23 Chinese children with CHI who underwent pancreatectomy.
  • Review of clinical data, ¹⁸F-DOPA PET/CT findings, and follow-up outcomes.
  • Correlation of preoperative imaging with surgical type and postoperative glycemic control.

Main Results:

  • ¹⁸F-DOPA PET/CT correctly identified focal CHI in 14 patients, leading to successful partial pancreatectomy with 71% achieving normal blood glucose.
  • Subtotal or near-total pancreatectomy was performed in 3 diffuse CHI cases, resulting in normal blood glucose.
  • Six cases lacked preoperative scan data and underwent pancreatectomy directly due to severe hypoglycemia.

Conclusions:

  • ¹⁸F-DOPA PET/CT is a reliable tool for preoperative histological typing and lesion localization in CHI.
  • Partial pancreatectomy demonstrates a high cure rate for focal-type CHI.
  • Surgical intervention, guided by imaging, offers significant therapeutic benefits for children with CHI.
Abstract